REFERENCES
1. Tan JK, Bhate K. A global perspective on the epidemiology of acne.Br J Dermatol. 2015;172 Suppl 1:3-12.
2. Wolkenstein P, Machovcova A, Szepietowski JC, Tennstedt D, Veraldi S,
Delarue A. Acne prevalence and associations with lifestyle: a
cross-sectional online survey of adolescents/young adults in 7 European
countries. J Eur Acad Dermatol Venereol. 2018;32(2):298-306.
3. Ghodsi SZ, Orawa H, Zouboulis CC. Prevalence, severity, and severity
risk factors of acne in high school pupils: a community-based study.J Invest Dermatol. 2009;129(9):2136-2141.
4. Karciauskiene J, Valiukeviciene S, Gollnick H, Stang A. The
prevalence and risk factors of adolescent acne among schoolchildren in
Lithuania: a cross-sectional study. J Eur Acad Dermatol Venereol.2014;28(6):733-740.
5. Walker N, Lewis-Jones MS. Quality of life and acne in Scottish
adolescent schoolchildren: use of the Children’s Dermatology Life
Quality Index (CDLQI) and the Cardiff Acne Disability Index (CADI).J Eur Acad Dermatol Venereol. 2006;20(1):45-50.
6. Wu TQ, Mei SQ, Zhang JX, et al. Prevalence and risk factors of facial
acne vulgaris among Chinese adolescents. Int J Adolesc Med
Health. 2007;19(4):407-412.
7. Hanisah A, Omar K, Shah SA. Prevalence of acne and its impact on the
quality of life in school-aged adolescents in Malaysia. J Prim
Health Care. 2009;1(1):20-25.
8. Poli F, Dreno B, Verschoore M. An epidemiological study of acne in
female adults: results of a survey conducted in France. J Eur Acad
Dermatol Venereol. 2001;15(6):541-545.
9. Thiboutot D, Gollnick H, Bettoli V, et al. New insights into the
management of acne: an update from the Global Alliance to Improve
Outcomes in Acne group. J Am Acad Dermatol. 2009;60(5
Suppl):S1-50.
10. Prevost N, English JC. Isotretinoin: update on controversial issues.J Pediatr Adolesc Gynecol. 2013;26(5):290-293.
11. Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet
(London, England). 2012;379(9813):361-372.
12. Roman CJ, Cifu AS, Stein SL. Management of Acne Vulgaris.Jama. 2016;316(13):1402-1403.
13. Melnik BC. Apoptosis May Explain the Pharmacological Mode of Action
and Adverse Effects of Isotretinoin, Including Teratogenicity.Acta Derm Venereol. 2017;97(2):173-181.
14. Thiboutot DM, Dreno B, Abanmi A, et al. Practical management of acne
for clinicians: An international consensus from the Global Alliance to
Improve Outcomes in Acne. J Am Acad Dermatol. 2018;78(2 Suppl
1):S1-S23.e21.
15. Antoniou C, Dessinioti C, Sotiriadis D, et al. A multicenter,
randomized, split-face clinical trial evaluating the efficacy and safety
of chromophore gel-assisted blue light phototherapy for the treatment of
acne. Int J Dermatol. 2016;55(12):1321-1328.
16. Nikolis A, Fauverghe S, Scapagnini G, et al. An extension of a
multicenter, randomized, split-face clinical trial evaluating the
efficacy and safety of chromophore gel-assisted blue light phototherapy
for the treatment of acne. Int J Dermatol. 2018;57(1):94-103.
17. Edge D, Mellergaard M, Dam-Hansen C, et al. Fluorescent light
energy: the future for treating inflammatory skin conditions? The
Journal of Clinical and Aesthetic Dermatology. 2019.
18. Zago M, Dehghani M, Jaworska J, et al. Fluorescent light
energy in wound healing: when is a photon something more? Vol 11221:
SPIE; 2020.
19. Scapagnini G, Marchegiani A, Rossi G, et al. Management of all
three phases of wound healing through the induction of fluorescence
biomodulation using fluorescence light energy. Vol 10863: SPIE; 2019.
20. Nast A, Dreno B, Bettoli V, et al. European evidence-based (S3)
guideline for the treatment of acne - update 2016 - short version.J Eur Acad Dermatol Venereol. 2016;30(8):1261-1268.
21. Lee JW, Yoo KH, Park KY, et al. Effectiveness of conventional,
low-dose and intermittent oral isotretinoin in the treatment of acne: a
randomized, controlled comparative study. Br J Dermatol.2011;164(6):1369-1375.
22. Van TLT, Minh PN, Thuy PTT, et al. Efficacy of Oral Low-Dose
Isotretinoin in the Treatment of Acne Vulgaris in Vietnam. Open
Access Maced J Med Sci. 2019;7(2):279-282.
23. Lehucher-Ceyrac D, de La Salmoniere P, Chastang C, Morel P.
Predictive factors for failure of isotretinoin treatment in acne
patients: results from a cohort of 237 patients. Dermatology.1999;198(3):278-283.
24. Chivot M. [Acne flare-up and deterioration with oral
isotretinoin]. Ann Dermatol Venereol. 2001;128(3 Pt 1):224-228.
25. Mehra T, Borelli C, Burgdorf W, Rocken M, Schaller M. Treatment of
severe acne with low-dose isotretinoin. Acta Derm Venereol.2012;92(3):247-248.
26. Allison MA, Dunn CL, Person DA. Acne fulminans treated with
isotretinoin and ”pulse” corticosteroids. Pediatr Dermatol.1997;14(1):39-42.
27. Katsambas A, Dessinioti C. New and emerging treatments in
dermatology: acne. Dermatol Ther. 2008;21(2):86-95.
28. Hamilton FL, Car J, Lyons C, Car M, Layton A, Majeed A. Laser and
other light therapies for the treatment of acne vulgaris: systematic
review. Br J Dermatol. 2009;160(6):1273-1285.
29. Mariwalla K, Rohrer TE. Use of lasers and light-based therapies for
treatment of acne vulgaris. Lasers in surgery and medicine.2005;37(5):333-342.
30. Haedersdal M, Togsverd-Bo K, Wulf HC. Evidence-based review of
lasers, light sources and photodynamic therapy in the treatment of acne
vulgaris. J Eur Acad Dermatol Venereol. 2008;22(3):267-278.
31. Barbaric J, Abbott R, Posadzki P, et al. Light therapies for acne:
abridged Cochrane systematic review including GRADE assessments.Br J Dermatol. 2018;178(1):61-75.
32. Sadick NS, Cardona A. Laser treatment for facial acne scars: A
review. J Cosmet Laser Ther. 2018;20(7-8):424-435.
33. Wiznia LE, Stevenson ML, Nagler AR. Laser treatments of active acne.Lasers in medical science. 2017;32(7):1647-1658.
34. Alexiades M. Laser and light-based treatments of acne and acne
scarring. Clin Dermatol. 2017;35(2):183-189.
35. Gold MH, Goldberg DJ, Nestor MS. Current treatments of acne:
Medications, lights, lasers, and a novel 650-mus 1064-nm Nd: YAG laser.J Cosmet Dermatol. 2017;16(3):303-318.
36. Tong LX, Brauer JA. Lasers, Light, and the Treatment of Acne: A
Comprehensive Review of the Literature. J Drugs Dermatol.2017;16(11):1095-1102.
37. Marson JW, Baldwin HE. An Overview of Acne Therapy, Part 1: Topical
therapy, Oral Antibiotics, Laser and Light Therapy, and Dietary
Interventions. Dermatol Clin. 2019;37(2):183-193.
38. Perper M, Tsatalis J, Eber AE, Cervantes J, Nouri K. Lasers in the
treatment of acne. G Ital Dermatol Venereol. 2017;152(4):360-372.
39. Posadzki P, Car J. Light Therapies for Acne. JAMA Dermatol.2018;154(5):597-598.
40. Scott AM, Stehlik P, Clark J, et al. Blue-Light Therapy for Acne
Vulgaris: A Systematic Review and Meta-Analysis. Ann Fam Med.2019;17(6):545-553.
41. Salavastru C, Tiplica GS, Branisteanu DE, Fritz K. [Light-based
inflammatory acne treatments]. Hautarzt. 2018;69(1):27-34.
42. Boen M, Brownell J, Patel P, Tsoukas MM. The Role of Photodynamic
Therapy in Acne: An Evidence-Based Review. Am J Clin Dermatol.2017;18(3):311-321.
43. Riddle CC, Terrell SN, Menser MB, Aires DJ, Schweiger ES. A review
of photodynamic therapy (PDT) for the treatment of acne vulgaris.J Drugs Dermatol. 2009;8(11):1010-1019.
44. Zheng W, Wu Y, Xu X, Gao X, Chen HD, Li Y. Evidence-based review of
photodynamic therapy in the treatment of acne. Eur J Dermatol.2014;24(4):444-456.
45. Pei S, Inamadar AC, Adya KA, Tsoukas MM. Light-based therapies in
acne treatment. Indian Dermatol Online J. 2015;6(3):145-157.
46. Nast A, Dreno B, Bettoli V, et al. European evidence-based (S3)
guidelines for the treatment of acne. J Eur Acad Dermatol
Venereol. 2012;26 Suppl 1:1-29.
47. Jalili A. Chromophore gel-assisted phototherapy: A novel and
promising photobiomodulation therapy for facial inflammatory skin
diseases and skin aging. Vol 112018.
48. Jalili A. Chromophore gel-assisted phototherapy. Journal für
Ästhetische Chirurgie. 2019;12(1):1-5.
49. Boyd JM, Lewis KA, Mohammed N, et al. Propionibacterium acnes
susceptibility to low-level 449 nm blue light photobiomodulation.Lasers in surgery and medicine. 2019;51(8):727-734.
50. Hamblin MR. Mechanisms and applications of the anti-inflammatory
effects of photobiomodulation. AIMS biophysics.2017;4(3):337-361.
51. Braun SA, Gerber PA. A photoconverter gel-assisted blue light
therapy for the treatment of rosacea. Int J Dermatol.2017;56(12):1489-1490.
52. Sannino M, Lodi G, Dethlefsen MW, Nistico SP, Cannarozzo G, Nielsen
MCE. Fluorescent light energy: Treating rosacea subtypes 1, 2, and 3.Clin Case Rep. 2018;6(12):2385-2390.
53. Gerber PA, Scarcella G, Edge D, Nielsen MCE. Biophotonic
pretreatment enhances the targeting of senile lentigines with a 694 nm
QS-ruby laser. Photodermatol Photoimmunol Photomed. 2019.
54. Scarcella G, Dethlefsen MW, Nielsen MCE. Treatment of solar
lentigines using a combination of picosecond laser and biophotonic
treatment. Clin Case Rep. 2018;6(9):1868-1870.
55. Mahendran A, Wong XL, Kao S, Sebaratnam DF. Treatment of
erlotinib-induced acneiform eruption with chromophore gel-assisted
phototherapy. Photodermatol Photoimmunol Photomed.2019;35(3):190-192.
56. Koceva I, Rummelein B, Gerber PA, Edge D, Nielsen MCE. Fluorescent
light energy: A new therapeutic approach to effectively treating acne
conglobata and hidradenitis suppurativa. Clin Case Rep.2019;7(9):1769-1772.
57. Nikolis A, Bernstein S, Kinney B, Scuderi N, Rastogi S, Sampalis JS.
A randomized, placebo-controlled, single-blinded, split-faced clinical
trial evaluating the efficacy and safety of KLOX-001 gel formulation
with KLOX light-emitting diode light on facial rejuvenation. Clin
Cosmet Investig Dermatol. 2016;9:115-125.
58. Romanelli M, Piaggesi A, Scapagnini G, et al. Evaluation of
fluorescence biomodulation in the real-life management of chronic
wounds: the EUREKA trial. J Wound Care. 2018;27(11):744-753.
59. Fogacci T, Cattin F, Semprini G, Frisoni G, Fabiocchi L, Samorani D.
The use of chromophore gel-assisted blue light phototherapy (Lumiheal)
for the treatment of surgical site infections in breast surgery.Breast J. 2018;24(6):1135.
60. M Mellergaard SF, C Scarpa, VL Pozner, S Skov, L Hebert, M Nielsen,
F Bassetto, and L Téot Evaluation of Fluorescent Light Energy for the
Treatment of Acute Second-degree Burns and Scars. article
submitted to Military Medicine Jan 2020.
61. Ding J MM, Kwana P, Edge D, Ma Z, Zhu Z, Hebert L, Alrobaiea S,
Iwasaki T, Nielsen MCE, and Tredget EE. Fluorescence light energy (FLE)
accelerates wound closure and re-epithelialization in a skin graft mouse
model. Submitted to Frontiers in Bioengineering and
Biotechnology. 2020.
62. Ferroni L, Zago M, Patergnani S, et al. Fluorescent Light Energy
(FLE) Acts on Mitochondrial Physiology Improving Wound Healing. J
Clin Med. 2020;9(2).
63. Bettoli V, Guerra-Tapia A, Herane MI, Piquero-Martín J. Challenges
and Solutions in Oral Isotretinoin in Acne: Reflections on 35 Years of
Experience. Clin Cosmet Investig Dermatol. 2019;12:943-951.
64. Layton A. The use of isotretinoin in acne. Dermatoendocrinol.2009;1(3):162-169.
65. Mellergaard M, Eguren, C, Romero, D, Bordignon, M, Darwich, E,
Pauletti, L, Guareschi, ME, Ricart, JM, Nielsen, MCE. Consensus-based
alternative regimes for treating acne and rosacea using fluorescent
light energy with low-dose isotretinoin. Under review: Journal of
Drugs in Dermatology. 2020.
66. Guidance for Industry; Acne Vulgaris: Developing Drugs for Treatment
(Draft Guidance).
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM071292.pdf2005:1-14.
67. Methicillin-resistant Staphylococcus aureus. Nature reviews
Disease primers. 2018;4:18034.
68. Tan JK, Tang J, Fung K, et al. Development and validation of a
comprehensive acne severity scale. J Cutan Med Surg.2007;11(6):211-216.
69. Dreno B, Bettoli V, Ochsendorf F, Layton A, Mobacken H, Degreef H.
European recommendations on the use of oral antibiotics for acne.Eur J Dermatol. 2004;14(6):391-399.
70. Del Rosso JQ, Thiboutot D, Gallo R, et al. Consensus recommendations
from the American Acne & Rosacea Society on the management of rosacea,
part 3: a status report on systemic therapies. Cutis.2014;93(1):18-28.
71. Simonart T, Dramaix M, De Maertelaer V. Efficacy of tetracyclines in
the treatment of acne vulgaris: a review. Br J Dermatol.2008;158(2):208-216.
72. Chon SY, Doan HQ, Mays RM, Singh SM, Gordon RA, Tyring SK.
Antibiotic overuse and resistance in dermatology. Dermatol Ther.2012;25(1):55-69.